REDAAT - Registro Español de Pacientes con Déficit Alfa-1 Antritipsina
Usuario:
Clave:
   
Olvidé mi constraseña

Publicaciones del registro interior

Publicaciones del registro internacional

Documentos de interés

Otras publicaciones relacionadas de interés

Publicaciones del registro español

  1. Vidal R, Blanco I, Casas F, Jardi R, Miravitlles M.
    Diagnóstico y tratamiento del déficit de alfa-1antitripsina.
    Arch Bronconeumol 2006 Dec;42(12):645-59. www.archbronconeumol.org
  2. Rodriguez F, de la Roza C, Jardi R, Schaper M, Vidal R, Miravitlles M.
    Glutathione S-Transferase P1 and Lung Function in Patients With alpha 1- antitrypsin deficiency and COPD.
    Chest. 2005;127(5):1537-43.
  3. De la Roza C, Costa X, Vidal R, Vila S, Rodriguez-Frias F, Jardi R, Miravitlles M.
    Screening program for alpha-1 antitrypsin deficiency in patients with chronic obstructive pulmonary disease, using dried blood spots on filter paper.
    Arch Bronconeumol. 2003;39(1):8-12.
  4. Miravitlles M, Vilà S, Torrella M, Balcells E, Rodríguez-Frías, de la Roza C, Jardí R, Vidal R.
    Influence of deficient alpha-1-antitrypsin phenotypes on clinical characteristics and severity of asthma in adults.
    Respir Med 2002; 96: 186-192.
  5. Rodríguez F, Jardí R, Costa X, Cotrina M, Galimany R, Vidal R, Miravitlles M.
    Rapid screening for alpha-1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood spots.
    Am J Respir Crit Care Med 2002; 166: 814-817.
  6. Luisetti M, Miravitlles M, Stockley RA.
    Alpha-1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001.
    Eur Respir J 2002; 20: 1050-1056.
  7. Jardí R, Rodríguez-Frías F, Lopez-Talavera JC, Miravitlles M, Cotrina M, Costa X, Pascual C, Vidal R.
    Characterization of the new alpha-1-antitrypsin deficient PI M-type allele, PI Mvall d'hebron (Pro369-Ser).
    Human Hered 2000; 50; 320-321.
  8. Costa X, Jardí R, Rodríguez F, Miravitlles M, Cotrina M, Pascual C, Vidal R.
    Easy method for screening dried blood spot specimens on filter paper for alpha-1 antitrypsin deficiency.
    Eur Respir J 2000; 15: 1111-1115.
  9. Miravitlles M.
    Alpha-1-antitrypsin deficiency: epidemiology and prevalence.
    Respir Med 2000; 94 (Suppl C): S12-S15.
  10. Blanco I, Bustillo EF, Rodríguez MC.
    a1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys.
    (In press)
  11. Blanco I, Bustillo EF, Rodríguez MC.
    Distribution of a1-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysis. Clin Genet 2001; 60: 000-000 (In press).
    Received 31 July 2001; revised and accepted for publication 26 September 2001
  12. Miravitlles M, de Gracia J, Rodrigo MJ, Cruz MJ, Vendrell M, Vidal R, Morell F.
    Specific antibody response against the 23-valent pneumococcal vaccine in patients with alpha-1-antitrypsin deficiency with and without bronchiectasis.
    Chest 1999; 116: 946-952.
  13. Miravitlles M, Vidal R, Barros-Tizón JC, Bustamante A, España PP, Casas F, Martínez MT, Escudero C, Jardí R.
    Estado actual del tratamiento sustitutivo en el enfisema congénito por déficit de alfa-1-antitripsina. Informe del registro nacional.
    Arch Bronconeumol 1999; 35: 446-454.
  14. Blanco I, Fernández E, Rodríguez MC, Fernández A.
    Frecuencias alélicas del gen de la alfa-1-antitripsina en la población general de una comarca de Asturias.
    Med Clin (Barc) 1999; 133: 366-370.
  15. Miravitlles M, Vidal R, Barros-Tizón JC, Bustamante A, España PP, Casas F, Martínez MT, Escudero C, Jardí R.
    Usefulness of a national Registry of alpha-1-antitrypsin deficiency. The Spanish experience.
    Respir Med 1998; 92: 1181-1187.
  16. Vidal R, Miravitlles M y Grupo de Estudio del déficit de alfa-1-antitripsina.
    Informe del Registro Español de Pacientes con déficit de alfa-1-antitripsina.
    Arch Bronconeumol 1995; 31: 299 -302.

volver menú principalvolver menú  

Publicaciones del registro internacional

  1. Stockley RA, Luissetti M,miravitlles M, Piituilainen E, Fernández P.
    Alpha One International Registry (AIR) group.
    Ongoing research in Europe: AIR objectives and development. Eur Respir J 2007 Mar;29(3):582-6.

volver menú principalvolver menú  

Documentos de interés

volver menú principalvolver menú  

Otras publicaciones relacionadas de interés

  1. Tirado-Conde G., Lara B., Miravitlles M.
    Augmentation therapy for emphysema due to alpha-1 antitrypsin deficiency.
    Therapeutic Advances in Respiratory disease. 2008:2(1);13-21. http://tar.sagepub.com
  2. De Serres, Balnco I, Fernández-Bustillo E.
    PIS and PIZ alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data.
    Monaldi Arch Chest Dis 2007;67(4): 184-208.
  3. Lara B., de la Roza C., Vilà S., Vidal R., Miravitlles M.
    Development and results of the Spanish Registry of patients with alpha-1-antitrypsin deficiency.
    Int J COPD 2007:2(3);1-6.
  4. Soy D., De la Roza C., Lara B., Esquinas C., Torres A., Miravitlles M.
    Alpha-1-antitrypsin deficiency: optimal therapeutic regime based on population pharmacokinetics.
    Thorax 2006 Dec; 61(12):1059-64.
  5. De Serres FJ, Blanco I, Fernandez-Bustillo E.
    Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
    COPD 2006;3(3):133-9.
  6. Blanco I, De Serres FJ, Fernandez-Bustillo E, Lara B, Miravitlles M.
    Estimated numbers and prevalence of PI*S and PI*Z alleles for alpha-1 antitrypsin deficiency in European countries.
    Eur Respìr J.2006;27(1):77-84.
  7. Blanco I., de Serres FJ, Fernández-Bustillo E., Lara B., Miravitlles M.
    Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha-1-antitrypsin deficiency in European countries.
    Eur Resp J 2006 Jan;27(1): 77-84.
  8. De la Roza C., Lara B., Vilà S., Miravitlles M.
    Déficit de alfa-1 antitripsina: situación en España y desarrollo de un programa de detección de casos.
    Arch Bronconeumol 2006 Jun;42(6):290-8.
  9. De la Roza C., Rodriguez-Frias F., Lara B., Vidal R., Miravitlles M.
    Results of a case-detection programme for alpha-1-antitrypsin deficiency in COPD patients.
    Eur Respir J. 2005 Oct;26(4):616-22.
  10. Gompertz S, Hill AT, Bayley DL, Stockley RA.
    Effect of expectoration on inflammation in induced sputum in alpha-1-antitrypsin deficiency.
    Respir Med. 2005 Oct 26
  11. Stolk J.
    Case detection of alpha-1-antitrypsin deficiency: does it help the patient or the doctor?
    Eur Respir J. 2005 Oct;26(4):561-2.
  12. Strange C, Stoller JK, Sandhaus RA, Dickson R, Turino G.
    Results of a Survey of Patients with Alpha-1 Antitrypsin Deficiency.
    Respiration. 2005 Aug 23
  13. Needham M, Stockley RA.
    Exacerbations in alpha-1-antitrypsin deficiency.
    Eur Respir J. 2005 Jun;25(6):992-1000.
  14. Rodriguez F, de la Roza C, Jardi R, Schaper M, Vidal R, Miravitlles M.
    Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD.
    Chest. 2005 May;127(5):1537-43.
  15. Stoller JK, Tomashefski J Jr, Crystal RG, Arroliga A, Strange C, Killian DN, Schluchter MD, Wiedemann HP.
    Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry.
    Chest. 2005 Apr;127(4):1196-204.
  16. De Serres FJ, Blanco I, Fernandez-Bustillo E.
    Health implications of alpha1-antitrypsin deficiency in Sub-Sahara African countries and their emigrants in Europe and the New World.
    Genet Med. 2005 Mar;7(3):175-84. Review.
  17. Abboud RT, Ford GT, Chapman KR.
    Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?.
    Treat Respir Med. 2005;4(1):1-8
  18. Blanco I, Fernández-Bustillo E, De Serres FJ, Alkassam D, Rodríguez C.
    PI*S yPI*Z: prevalencia estimada y número de sujetosdeficientes en España.
    Med Clin (Barc) 2004 Dic 4; 123(20):761-5.
  19. ATS/ERS statement: Standars for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.
    Am J Respir Crit Care Med 2003;168:820-900.
  20. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DCS, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, Vrooman HA, Reiber JHC, Hansen NC, Heckscher T, Viskum K, Stolk J.
    A Randomized Clinical Trial of 1-Antitrypsin Augmentation Therapy.
    Am. J. Respir. Crit. Care Med., 1999; 160: 1468-1472.
  21. Blanco I, Fernández E, Rodríguez MC, Fernández A.
    Allelic frequency of the gene of alpha-1-antitrypsin in the general population in a county in Asturias.
    Med Clin (Barc) 1999; 113(10): 366-70.
  22. Alpha-1-Antitrypsin Deficiency Registry Study Group.
    Survival and FEV1 decline in individuals with severe deficiency of alpha-1-antitrypsin.
    Am J Respir Crit Care Med 1998;158:49-59.
  23. Miravitlles M.
    ¿Debemos administrar tratamiento sustitutivo a los pacientes con déficit de alfa-1-antitripsina? (editorial).
    Arch Bronconeumol 1998; 34: 109-111.
  24. McElvaney N, Stoller J, Buist A, et al.
    Baseline characteristics of enrollees in the National Heart, Lung and Blood Insitute registry of alpha-1-antitrypsin deficiency.
    Chest 1997; 111:394-403.
  25. Stoller J, Buist A, Burrows B, et al.
    Quality control of spirometry testing in the registry of patients with severe alpha-1-antitrypsin deficiency.
    Chest 1997; 111: 899-909.
  26. Pierce JA.
    Alpha-1-Antitrypsin augmentation therapy (editorial).
    Chest 1997; 112, 4.
  27. Seersholm N, Wencker M, et al.
    Does alpha-1-antitrypsin augmentation therapy slow the annual decline in FEVI in patients with severe hereditary alpha-1-antittypsin deficiency?
    Eur Respir J 1997; 10: 2260-3.
  28. Jardí R, Rodríguez-Frías F, Casas F, Cotrina M, Vidal R, Miravitlles M, Pascual C.
    Caracterización molecular de dos variantes deficitarias de la alfa-1-antitripsina: PI Mpalermo y PI Plovel.
    Med Clin (Barc) 1997; 109: 463-466.
  29. Siofakos NM, Vermiere P, Pride NB, et al.
    Optimal treatment and management of chronic obstructive pulmonary disease (COPD).
    Eur Resp J 1995; 8: 1398-1420.
  30. Alpha-1-Antitrypsin Deficiency Registry Study Group.
    A registry of patients with severe deficiency of alpha-1-antitrypsin: design and methods.
    Chest 1994; 106:1223-32.

volver menú principalvolver menú